Le SIDA en Afrique subsaharienne (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 001F27 ( Pmc/Corpus ); précédent : 001F269; suivant : 001F280 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications</title>
<author>
<name sortKey="Boccia, D" sort="Boccia, D" uniqKey="Boccia D" first="D." last="Boccia">D. Boccia</name>
<affiliation>
<nlm:aff id="A1">Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hargreaves, J" sort="Hargreaves, J" uniqKey="Hargreaves J" first="J." last="Hargreaves">J. Hargreaves</name>
<affiliation>
<nlm:aff id="A1">Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lonnroth, K" sort="Lonnroth, K" uniqKey="Lonnroth K" first="K." last="Lönnroth">K. Lönnroth</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jaramillo, E" sort="Jaramillo, E" uniqKey="Jaramillo E" first="E." last="Jaramillo">E. Jaramillo</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Weiss, J" sort="Weiss, J" uniqKey="Weiss J" first="J." last="Weiss">J. Weiss</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Uplekar, M" sort="Uplekar, M" uniqKey="Uplekar M" first="M." last="Uplekar">M. Uplekar</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Porter, J D H" sort="Porter, J D H" uniqKey="Porter J" first="J. D. H." last="Porter">J. D. H. Porter</name>
<affiliation>
<nlm:aff id="A3">Faculty of Tropical and Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Evans, C A" sort="Evans, C A" uniqKey="Evans C" first="C. A." last="Evans">C. A. Evans</name>
<affiliation>
<nlm:aff id="A4">Faculty of Sciences and Philosophy, Universidad Peruana Cayetano Heredia, Lima, Peru</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">21740658</idno>
<idno type="pmc">3160484</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160484</idno>
<idno type="RBID">PMC:3160484</idno>
<idno type="doi">10.5588/ijtld.10.0438</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">001F27</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001F27</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications</title>
<author>
<name sortKey="Boccia, D" sort="Boccia, D" uniqKey="Boccia D" first="D." last="Boccia">D. Boccia</name>
<affiliation>
<nlm:aff id="A1">Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Hargreaves, J" sort="Hargreaves, J" uniqKey="Hargreaves J" first="J." last="Hargreaves">J. Hargreaves</name>
<affiliation>
<nlm:aff id="A1">Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lonnroth, K" sort="Lonnroth, K" uniqKey="Lonnroth K" first="K." last="Lönnroth">K. Lönnroth</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jaramillo, E" sort="Jaramillo, E" uniqKey="Jaramillo E" first="E." last="Jaramillo">E. Jaramillo</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Weiss, J" sort="Weiss, J" uniqKey="Weiss J" first="J." last="Weiss">J. Weiss</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Uplekar, M" sort="Uplekar, M" uniqKey="Uplekar M" first="M." last="Uplekar">M. Uplekar</name>
<affiliation>
<nlm:aff id="A2">Stop TB Department, World Health Organization, Geneva, Switzerland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Porter, J D H" sort="Porter, J D H" uniqKey="Porter J" first="J. D. H." last="Porter">J. D. H. Porter</name>
<affiliation>
<nlm:aff id="A3">Faculty of Tropical and Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Evans, C A" sort="Evans, C A" uniqKey="Evans C" first="C. A." last="Evans">C. A. Evans</name>
<affiliation>
<nlm:aff id="A4">Faculty of Sciences and Philosophy, Universidad Peruana Cayetano Heredia, Lima, Peru</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</title>
<idno type="ISSN">1027-3719</idno>
<idno type="eISSN">1815-7920</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>OBJECTIVE</title>
<p id="P1">To quantify the impact of cash transfer and microfinance interventions on a selected list of tuberculosis (TB) risk factors and assess their potential role in supporting TB control.</p>
</sec>
<sec id="S2">
<title>DATA SOURCE</title>
<p id="P2">Published and unpublished references identified from clinical and social electronic databases, grey literature and web sites.</p>
</sec>
<sec id="S3">
<title>METHODS</title>
<p id="P3">Eligible interventions had to be conducted in middle- or low-income countries and document an impact evaluation on any of the following outcomes: 1) TB or other respiratory infections; 2) household socio-economic position; and 3) factors mediating the association between low household socio-economic position and TB, including inadequate health-seeking behaviours, food insecurity and biological TB risk factors such as human immunodeficiency virus (HIV) and adult malnutrition. Interventions targeting special populations were excluded.</p>
</sec>
<sec id="S4">
<title>RESULTS</title>
<p id="P4">Fifteen cash transfer schemes (four unconditional and 11 conditional) and seven microfinance programmes met the eligibility criteria. No intervention addressed TB or any other respiratory infection. Of 11 cash transfer and four microfinance interventions, respectively seven and four reported a positive impact on indicators of economic well-being. A positive impact on household food security was documented in respectively eight of nine and three of five cash transfer and microfinance interventions. Improved health care access was documented respectively in 10 of 12 cash transfer and four of five microfinance interventions. The only intervention evaluating impact on HIV incidence was a microfinance project that found no effect. No cash transfer or microfinance interventions had an impact on adult malnutrition.</p>
</sec>
<sec id="S5">
<title>CONCLUSIONS</title>
<p id="P5">Cash transfer and microfinance interventions can positively impact TB risk factors. Evaluation studies are urgently needed to assess the impact of these social protection interventions on actual TB indicators.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9706389</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20773</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Tuberc Lung Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Int. J. Tuberc. Lung Dis.</journal-id>
<journal-title-group>
<journal-title>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">1027-3719</issn>
<issn pub-type="epub">1815-7920</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">21740658</article-id>
<article-id pub-id-type="pmc">3160484</article-id>
<article-id pub-id-type="doi">10.5588/ijtld.10.0438</article-id>
<article-id pub-id-type="manuscript">UKMS35470</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Boccia</surname>
<given-names>D.</given-names>
</name>
<xref ref-type="aff" rid="A1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hargreaves</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="A1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lönnroth</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="A2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaramillo</surname>
<given-names>E.</given-names>
</name>
<xref ref-type="aff" rid="A2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weiss</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="A2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uplekar</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="A2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Porter</surname>
<given-names>J. D. H.</given-names>
</name>
<xref ref-type="aff" rid="A3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Evans</surname>
<given-names>C. A.</given-names>
</name>
<xref ref-type="aff" rid="A4">§</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>*</label>
Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK</aff>
<aff id="A2">
<label></label>
Stop TB Department, World Health Organization, Geneva, Switzerland</aff>
<aff id="A3">
<label></label>
Faculty of Tropical and Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK</aff>
<aff id="A4">
<label>§</label>
Faculty of Sciences and Philosophy, Universidad Peruana Cayetano Heredia, Lima, Peru</aff>
<author-notes>
<corresp id="CR1">Correspondence to: Delia Boccia, Faculty of Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK. Tel: (+44) 207 958 8145.
<email>delia.boccia@lshtm.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>5</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>24</day>
<month>8</month>
<year>2011</year>
</pub-date>
<volume>15</volume>
<issue>Suppl 2</issue>
<fpage>S37</fpage>
<lpage>S49</lpage>
<permissions>
<copyright-statement>© 2011 The Union</copyright-statement>
<copyright-year>2011</copyright-year>
</permissions>
<abstract>
<sec id="S1">
<title>OBJECTIVE</title>
<p id="P1">To quantify the impact of cash transfer and microfinance interventions on a selected list of tuberculosis (TB) risk factors and assess their potential role in supporting TB control.</p>
</sec>
<sec id="S2">
<title>DATA SOURCE</title>
<p id="P2">Published and unpublished references identified from clinical and social electronic databases, grey literature and web sites.</p>
</sec>
<sec id="S3">
<title>METHODS</title>
<p id="P3">Eligible interventions had to be conducted in middle- or low-income countries and document an impact evaluation on any of the following outcomes: 1) TB or other respiratory infections; 2) household socio-economic position; and 3) factors mediating the association between low household socio-economic position and TB, including inadequate health-seeking behaviours, food insecurity and biological TB risk factors such as human immunodeficiency virus (HIV) and adult malnutrition. Interventions targeting special populations were excluded.</p>
</sec>
<sec id="S4">
<title>RESULTS</title>
<p id="P4">Fifteen cash transfer schemes (four unconditional and 11 conditional) and seven microfinance programmes met the eligibility criteria. No intervention addressed TB or any other respiratory infection. Of 11 cash transfer and four microfinance interventions, respectively seven and four reported a positive impact on indicators of economic well-being. A positive impact on household food security was documented in respectively eight of nine and three of five cash transfer and microfinance interventions. Improved health care access was documented respectively in 10 of 12 cash transfer and four of five microfinance interventions. The only intervention evaluating impact on HIV incidence was a microfinance project that found no effect. No cash transfer or microfinance interventions had an impact on adult malnutrition.</p>
</sec>
<sec id="S5">
<title>CONCLUSIONS</title>
<p id="P5">Cash transfer and microfinance interventions can positively impact TB risk factors. Evaluation studies are urgently needed to assess the impact of these social protection interventions on actual TB indicators.</p>
</sec>
</abstract>
<kwd-group>
<kwd>tuberculosis</kwd>
<kwd>cash</kwd>
<kwd>microcredit</kwd>
<kwd>impact</kwd>
<kwd>review</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source country="United Kingdom">Wellcome Trust : </funding-source>
<award-id>057434 || WT</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F27  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001F27  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024